Professional Documents
Culture Documents
Cerumen Impaction
• ear wax is a mixture of secretions from ceruminous and
pilosebaceous glands, squames of epithelium, dust, and debris
Risk Factors
• hairy or narrow ear canals, in-the-ear hearing aids, cotton
swab usage, osteomata
Clinical Features
• hearing loss (conductive)
• tinnitus, vertigo, otalgia, aural fullness
Treatment
• ceruminolytic drops (bicarbonate solution, olive oil, glycerine)
• syringing
• manual debridement
• Cerumen impaction is the most common cause of conductive
hearing loss in 15 to 50 year olds.
SYRINGING
Indications
• totally occlusive cerumen with pain, decreased hearing, or tinnitus
Contraindications
• non-occlusive cerumen, previous ear surgery, only
hearing ear, TM perforation
Complications
• failure, otitis externa, TM perforation, vertigo...
Method
• establish TM is intact
• gently pull the pinna up and back
• using warm water, aim the syringe nozzle upwards and
posteriorly to irrigate the ear canal
Otitis Externa (OE)
Etiology
• bacteria (~90% of OE): Pseudomonas aeruginosa,
Pseudomonas vulgaris, E. coli, S. aureus
• fungus: Candida albicans, Aspergillus niger
Risk Factors
• associated with swimming (“swimmer’s ear”)
• mechanical cleaning , skin dermatitides, aggressive scratching
• devices that occlude the ear canal: hearing aids, headphones,
etc.
Clinical Features
• acute
• pain aggravated by movement of auricle (tragal tenderness)
• otorrhea (sticky yellow purulent discharge)
• conductive hearing loss , aural fullness 2o to obstruction of
external canal by swelling and purulent debris
• post-auricular lymphadenopathy
• complicated OE exists if the pinna and/or the periauricular soft
tissues are erythematous and swollen
• chronic
• pruritus of external ear , excoriation of ear canal
• atrophic and scaly epidermal lining , otorrhea , hearing loss
• wide meatus but no pain with movement of auricle
tympanic membrane appears normal
Treatment
• clean ear under magnification with irrigation, suction, dry
swabbing
• bacterial etiology
• antipseudomonal otic drops (e.g. gentamicin,
ciprofloxacin) or a combination of antibiotic and steroid
• do not use aminoglycoside if the tympanic membrane
(TM) is perforated because of the risk of ototoxicity
• systemic antibiotics if either cervical lymphadenopathy
or cellulitis
• fungal etiology
• repeated debridement and topical antifungals
( clotrimazol)
• analgesics
• chronic otitis externa (pruritus without obvious
infection) --> corticosteroid alone
Malignant (Necrotizing) Otitis Externa/Skull
Base Osteomyelitis
Causes
• Bell’s palsy(50%)
• Trauma(20%)
• Otitis media…
Bell’s palsy
Definition
• sensorineural hearing loss associated with aging (5th and 6th decades)
• Presbycusis is the most common cause of sensorineural hearing loss.
Etiology
• hair cell degeneration
• age related degeneration of basilar membrane
• cochlear neuron damage
• ischemia of inner ear
Clinical Features
• progressive, gradual bilateral hearing loss
• recruitment phenomenon: inability to tolerate loud sounds
tinnitus
Treatment
• hearing aid
Drug Ototoxicity
Aminoglycosides
• toxic to hair cells by any route: oral, IV, and topical (only if
the TM is perforated)
• destroys sensory hair cells – outer first, inner second
• ototoxicity occurs days to weeks post-treatment
• streptomycin and gentamicin (vestibulotoxic), kanamycin
and tobramycin (cochleotoxic)
• daily dosing presents less risk than divided daily
doses
• duration of treatment is the most important
predictor of ototoxicity
• treatment: immediately stop aminoglycosides
Noise-Induced Sensorineural Hearing Loss
Pathogenesis
• 85 to 90 dB over months or years causes cochlear damage
• early-stage hearing loss at 4000 Hz (because this is the resonance frequency
of the temporal bone) , extends to higher and lower frequencies with time
• speech reception not altered until hearing loss >30 dB at speech frequency,
therefore considerable damage may occur before patient complains of
hearing loss
• difficulty with speech discrimination, especially in situations with
competing noise
Limits of Noise Causing Damage
• continuous sound pressure >85 dB
• single sound impulse >135 dB
Diseases of the oral cavity & oropharynx
Acute Tonsillitis
Etiology
• Group A beta-hemolytic streptococcus and Group G streptococcus
• S. pneumonia, S. aureus, H. influenzae, M. catarrhalis
Clinical Features
• symptoms
• sore throat
• dysphagia, odynophagia, trismus
• malaise, fever
• otalgia (referred)
• signs
• tender cervical lymphadenopathy especially submandibular,
jugulodigastric
• tonsils enlarged, inflammation ± exudates/white follicles
• strawberry tongue, scarletiniform rash (scarlet fever)
• palatal petechiae (infectious mononucleosis)
Investigations
• CBC
.
Treatment
• bed rest, soft diet, ample fluid intake
• analgesics and antipyretics
• antibiotics
• 1st line penicillin or amoxicillin (erythromycin if penicillin allergic) x 10
days
• rheumatic fever risk emerges approximately 9 days after the onset
of symptoms: antibiotics are utilized mainly to avoid this serious sequela
and to provide earlier symptomatic relief
• no evidence for the role of antibiotics in the avoidance of post-streptococcal
glomerulonephritis
Complications
• deep neck space infection
• abscess: peritonsillar, intratonsillar
• sepsis
• glomerulonephritis
Adenoid hypertrophy
• Increase in size with allergy
and repeated URTI
• Clinical features
• Nasal obstruction
• Adenoid facies
• Hyponasal voice
• OSA
• Rhinitis/sinusitis
• PND and cough
• Recurrent OM
Adenoid Hypertrophy
adenoidal hypertrophy
ANTIGEN EXPOSURE and cellular response
continued exposure
of antigen in trapped nasopharyngeal obstruction
secretions and inspissation of secretions
immunologic memory
established
Adenoid Hypertrophy
• Absolute
Relative
• OSA, cor pulmonale
Tonsillar hypertrophy
• Suspect malignancy Recurrent tonsillitis
tonsillitis
• Severe dysphagia
- Recurrent Acute Tonsillitis (adults and children)
◦ 7 episodes within 1 year
◦ 4 -5 episodes per
year x2 years
◦ 3 episodes per year x3 years
Obstructive sleep apnoea syndrome
(OSAS)
• Definitions
• Apnoea
• Cessation of airflow at nostrils for 10 seconds or longer
• Apnoea index
• Number of apnoeas per hour of sleep
• Hypopnoea
• Reduction in airflow associated with desaturation
• Sleep apnoea syndrome
• 30 or more apnoeic episodes during a 7-hour sleep
Causes of OSAS
• Nose
• Polyps
• Deviated nasal septum
• Pharynx
• Adenoidal hypertrophy
• Nasopharyngeal tumor
• Large palatine/lingual tonsils
• Retropharyngeal mass
• Large tongue
• Obesity
Clinical features
• CBC
• Blood chemistry including LFTs
• CT/MRI
• CXR to r/o metastasis
Treatment
-Antibiotics
-surgery , radiation
Diseases of the nose & PNS
Allergic Rhinitis
• rhinitis characterized by an IgE-mediated hypersensitivity to foreign
allergens
• acute-and-seasonal or chronic-and-perennial
• perennial allergic rhinitis often confused with recurrent colds
Etiology
• when allergens contact the respiratory mucosa, specific IgE antibody is
produced in susceptible hosts
• concentration of allergen in the ambient air correlates directly with the
rhinitis symptoms
Epidemiology
• age at onset usually <20 years
more common in those with a personal or family Hx of
allergies
Clinical Features
• nasal: obstruction with pruritus, sneezing
• clear rhinorrhea (containing increased eosinophils)
• itching of eyes with tearing , frontal headache and pressure
• mucosa – swollen, pale, and “boggy”
• seasonal (summer, spring, early autumn)
• pollens from trees
• lasts several weeks, disappears and recurs following year at same
time
• perennial
• inhaled: house dust , wool, feathers, foods, tobacco, hair, mould
• ingested: wheat, eggs, milk, nuts
• occurs intermittently for years with no pattern or may be constantly
present
Diagnosis
• history & direct exam
Treatment
• education: identification and avoidance of allergen
• antihistamines e.g. diphenhydramine
Vasomotor Rhinitis